{"transactions":[{"id":2644332,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:38:15.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":12334,"price":1.52,"value":18747.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021."}],"balance_after":24485,"source":{"system":"sec-edgar","filing":"0000899243-21-027290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321027290/doc4.xml","form_type":"4"}},{"id":2760993,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-03T00:30:21.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":12151,"price":1.543,"value":18748.993,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended March 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended March 31, 2021."}],"balance_after":12151,"source":{"system":"sec-edgar","filing":"0000899243-21-014672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321014672/doc4.xml","form_type":"4"}},{"id":3098408,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T20:42:29.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":52144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":52144,"derivative":{"exercise_price":1.22,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":52144},"source":{"system":"sec-edgar","filing":"0000899243-20-017774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924320017774/doc4.xml","form_type":"4"}},{"id":3484023,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T21:24:38.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":21400,"derivative":{"exercise_price":0.96,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0000899243-19-017437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924319017437/doc4.xml","form_type":"4"}},{"id":3683638,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T17:42:26.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to 100% of the underlying shares on January 25, 2020, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.74,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-19-000578","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302315/000156218019000578/primarydocument.xml","form_type":"4"}},{"id":3884940,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T22:04:01.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":21400,"derivative":{"exercise_price":4,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0000899243-18-017749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924318017749/doc4.xml","form_type":"4"}},{"id":4086281,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T16:39:14.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30 and December 31, 2018."}],"balance_after":20000,"derivative":{"exercise_price":7.72,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-18-000480","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302315/000156218018000480/primarydocument.xml","form_type":"4"}},{"id":4477075,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-30T19:02:08.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017."}],"balance_after":20000,"derivative":{"exercise_price":2.01,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-002202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302315/000089924317002202/doc4.xml","form_type":"4"}},{"id":4517216,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":137609,"kind":"person","name":"Prelack Steven","position":1,"cik":"0001302315","reported_name":"Prelack Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2016-12-19T21:24:57.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":41500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting."}],"balance_after":41500,"derivative":{"exercise_price":0.89,"expiration_date":"2026-12-15","underlying":"Common stock","underlying_shares":41500},"source":{"system":"sec-edgar","filing":"0001179022-16-000131","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000117902216000131/edgar.xml","form_type":"4"}}]}